Which form is required for a pharmacy to register as a Narcotic Treatment Program?

A pharmacy seeking to register as a Narcotic Treatment Program must complete and submit DEA Form 363. This form is specifically designated for facilities that wish to treat individuals for opioid addiction using controlled substances. The registration process involves providing information about the facility, its proposed treatment activities, and compliance with both federal and state regulations.

By using Form 363, the pharmacy demonstrates its intent to adhere to the regulations that govern the dispensing of narcotics for the treatment of substance use disorders. This form ensures that the pharmacy meets the necessary legal requirements and standards set forth by the DEA for providing such specialized treatment.